The University of Sheffield
Health Economics and Decision Science

HEDS

Welcome to the Health Economics and Decision Science Section of ScHARR

The Section

The purpose of HEDS is to promote excellence in health care resource allocation decisions. HEDS makes major contributions in areas that include the valuation of health, the analysis of health policy, welfare and equity, technology appraisal,evidence synthesis, econometrics and information sciences.

We also lead several national research collaborations, supervise PhD students, contribute to Masters programmes, deliver external training courses and provide input to national committees. Find out more about our activities here or in the most recent issue of our newsletter.

Latest publications

The National Institute for Health and Clinical Excellence single technology appraisal process: Lessons from the first 4 years.  Value Health 14(8):1158-1165 Dec 2011

Reasons for the use and non-use of school sexual health services: a systematic review of young people's views.  J Public Health (Oxf) 18 Dec 2011

Using a discrete choice experiment to estimate health state utility values.  J Health Econ 06 Dec 2011

Consultancy

HEDS delivers a vibrant portfolio of consultancy-funded research to the pharmaceutical and medical devices sector and the NHS. It utilises our broad range of skills and is complemented by tailored training courses covering a full range of research methods, as well as policy issues such as pricing and reimbursement. Find out more about how we might work with you.

New HEDS projects

Modelling NHS carbon reduction strategies.  Contact Alan Brennan for further details.

Potential prediction of preterm labour and birth by magnetic induction spectroscopy.  Contact Simon Dixon for further details.

Section Director

Professor Simon Dixon

Deputy Section Director

Dr Eva Kaltenthaler

HEDS blog

The best way to keep up with our work and our impact on policy is to read the HEDS Blog. With over 10,000 hits from over 60 different countries recent blog posts also feature on Twitter:.